¡¡¡ DE CAMINO Y CON BUENA NOTA ... ANLOTINIB ORAL ( CAPSULA CON UN VASO DE AGUA ) PARA EL TRATAMIENTO DE SEGUNDA LINEA SMALL CELL LUNG CANCER ... !!! .

SMALL CELL LUNG CANCER  SEGUNDA LINEA . ANLOTINIB ORAL : OVERALL SURVIVAL DE 33,5 MESES DE MEDIA  Y UNA PFS DE 7,2 MESES DE MEDIA  . UNA OPCIÓN SUPERIOR PARA EL TRATAMIENTO DE SEGUNDA LÍNEA DEL CÁNCER DE PULMÓN DE CÉLULAS PEQUEÑAS EN ESTADIO EXTENSO . 

El Tratamiento con INHIBIDORES de PD-(L)1+ANLOTINIB ORAL ± QUIMIOTERAPIA Generó la mPFS ( 7,2 Meses ) y mOS ( 33,5 Meses Más Prolongada en Comparación con el Tratamiento con I+C (mPFS=4,6 Meses, mOS=19,0 Meses, Ambos P < 0,001) o C ( mSLP = 3,4 Meses, P <0,01; mOS = 18,3 meses, P = 0,083) .

Conclusiones :

Los INHIBIDORES de PD-(L)1 Más ANLOTINIB ORAL y/o QUIMIOTERAPIA Tienen una Eficacia Prometedora y una Toxicidad Manejable Como Terapia de SEGUNDA LÍNEA del ES-SCLC .

SERPLULIMAB BECOMES THE FIRST ANTI-PD-1 APPROVED FOR EXTENSIVE-STAGE SMALL CELL LUNG CANCER .///. SERPLULIMAB APORTA 4,9 MESES MÁS DE OVERALL SURVIVAL QUE ATEZOLIZUMAB EN SOLITARIO ... Y 2,2 MESES MÁS DE OVERALL SURVIVAL QUE ATEZOLIZUMAB COMBINADO CON LURBINECTEDIN .

 

Hawaii Lung 2025 // Corey Langer MD Discusses lMForte Trial And Role Of LURBINECTEDIN In Maintenance SMALL CELL LUNG CANCER , "" HOWEVER TOXICITY IS NOT TRIVIAL "" , Questioning This SOC , CONCERN FOR TOXICITY , Lack Of Crossover And How To Sequence TARLATAMAB .

 

AQUI EL CURRÍCULUM Y LA OPINIÓN DEL DOCTOR COREY LANGER ... SOBRE LOS RESULTADOS  PRESENTADOS DEL IMFORTE EN EL CONGRESO SOBRE PULMÓN EN HAWAI .

Corey J. Langer is a Professor of Medicine at the University of Pennsylvania, Perelman School of Medicine, where he serves as Clinical Director of Thoracic Oncology in the Abramson Cancer Center .

Professor Langer received his medical degree from Boston University in 1981 and completed his residency in medicine at the Graduate Hospital, University of Pennsylvania, and his hematology/oncology fellowship at Presbyterian University of Pennsylvania and Fox Chase Cancer Center in 1987 .

Professor Langer served in the Oncology division of Fox Chase Cancer Center from 1986–2008, leading its Thoracic Oncology Program from 1994–2008 . He moved to the University of Pennsylvania in 2008, where he currently leads clinical research efforts in thoracic malignancy as part of the Interdisciplinary Thoracic Oncology Program (I-TOP) and conducts research studies focused on the role of targeted therapy and immunotherapy in NSCLC .

He also co-directs the Thoracic Translational Center of Excellence, where he concentrates on the clinical end of bench to bedside projects .

Professor Langer is Co-Chair of the Medical Oncology Committee for NRG Cooperative Oncology Group and serves on the core thoracic committees of both NRG and ECOG . 

Professor Langer is a Fellow of the American College of Physicians and is a member of the American Society of Clinical Oncology (ASCO), the American Association for Cancer Research (AACR) and the International Association for the Study of Lung Cancer (IASLC) .

Since 2016, he has been Editor-in-Chief of the International Lung Cancer News (ILCN) UNDERWENT the aegis of the IASLC . 

For the past 34 years, since completing his fellowship, Professor Langer has led or co-led over 140 clinical trials in both SMALL CELL LUNG CANCER ( SCLC ) and NON-SMALL CELL LUNG CANCER ( NSCLC), as well as MESOTHELIOMA and HEAD and NECK CÁNCER .

 Professor Langer has contributed numerous articles and abstracts to the medical literature and is the author or co-author of over 270 peer-reviewed peer-revie papers .

IAG Y EL SECTOR AÉREO Y AUTOMOVILÍSTICO DE ENHORABUENA ... EL PETROLEO CAE EN EL PRIMER SEMESTRE UN 9% ... Y SIGUE CAYENDO . Y AHORA VIENE LO MEJOR === Bombazo Geológico : Hallan un Yacimiento del ‘ Petróleo del Futuro ’ Valorado en 100.000 MILLONES de € en Francia .

¡¡¡ CAMBIO DE PARADIGMA ENERGÉTICO !!! .

ESTAMOS ANTE EL PETRÓLEO DEL FUTURO ...

MÁS ECOLÓGICO .

MAS ECONOMICO .

Y A SOLO 1200 METROS DE PROFUNDIDAD .

Se trata de una forma específica de hidrógeno que podría ofrecer ventajas tanto económicas como medioambientales . 

Este tipo de recurso, radicado en algunas zonas del planeta, plantea la posibilidad de un cambio de paradigma energético .

Un reciente hallazgo en Europa central, muy cerca de España, ha vuelto a ponerlo en el foco de los análisis y proyecciones de futuro . ...